📩 20/02/2021 10:53
"Synovial conomatosis" and "Pigmented Nodular synovitis" Patients with rare joint diseases such as going to the TRNC from Turkey for treatment.
"Synovial conomatosis" and "Pigmented Nodular synovitis" Patients with rare joint diseases such as going to the TRNC from Turkey for treatment. The treatment of patients is carried out by the Departments of Nuclear Medicine, Orthopedics and Traumatology and Physical Medicine and Rehabilitation at the Near East University Hospital with a multidisciplinary approach.
Although it is more common in the knees, the treatment methods of these diseases that can affect all joints in the body include medication, surgery and steroid injection. However, traditional methods can sometimes be insufficient in treatment. In such cases, "radionuclide synevectomy" treatment, which is started to be applied at Near East University Hospital, is a hope for patients. Finally, treatment outgoing from Turkey to the TRNC, were both surgically treated before, synovial conomatosis diagnosed 27-year-old HA and pigmented nodular synovitis diagnosed 26-year-old NSC Near East University Hospital radionuclide with a successful application treatment was applied.
Positive Result in 15 Days
The success rate of radiosynevectomy treatment, whose positive effects are seen after 15 days, varies between 60 and 80 percent. The treatment, which can be performed without the need for anesthesia, can also be applied to joints in different parts of the body such as knees, hips and fingers. Near the beginning of radionuclide therapy to be applied in East University Hospital, especially from many foreign countries, including Turkey, the TRNC Synovial conomatosis patients began to go for treatment.
Making statements about the procedures applied to patients coming to TRNC from abroad, Near East University Hospital Nuclear Medicine Department Head Prof. Dr. Nuri Arslan, previously tried different treatments, but that came to our country for the treatment of patients who failed radionuclides and after treatments of health said they were discharged in Turkey.
Prof. Dr. Nuri Arslan: "Radionuclide treatment method has a high success rate reaching 80 percent."
Stating that the limitation of movement caused by pain and swelling caused by Synovial Chondromatosis and Pigmented Nodular Synovitis, which is a very distressing joint disease, although it is rarely seen, Prof. Dr. Nuri Arslan states that radionuclide therapy creates a ray of hope for patients who cannot be successful with surgery or who are likely to recur.
In the first stage of the treatment, fluid accumulated in the joint is drained. In the second step, the radioactive drug is given to the joint together with steroid and saline by injection method, and the radioactive drug is distributed evenly within the joint. The chances of success of the treatment can reach up to 80 percent, depending on the chronicity of the disease, the thickness of the synovial membrane and the success of the previous surgical intervention. Patients' pain and joint swelling are expected to begin to decrease in 2 to 3 weeks after treatment. In case of not getting enough results from the first treatment, the procedure can be repeated after the 6th month. Response to treatment is determined by clinical examination and MRI control after 1 month.